State Street Corporation 13D and 13G filings for Coherus BioSciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-22 2:08 pm Sale | 2023-12-31 | 13G | Coherus BioSciences, Inc. CHRS | STATE STREET CORP STT | 2,064,326 1.850% | -4,721,656 (-69.58%) | Filing |
| 2023-02-03 4:00 pm Purchase | 2022-12-31 | 13G | Coherus BioSciences, Inc. CHRS | STATE STREET CORP STT | 6,785,982 8.720% | 2,964,862 (+77.59%) | Filing |
| 2022-02-09 12:40 pm Sale | 2021-12-31 | 13G | Coherus BioSciences, Inc. CHRS | STATE STREET CORP STT | 3,821,120 4.980% | -797,930 (-17.27%) | Filing |
| 2021-02-08 08:30 am Purchase | 2020-12-31 | 13G | Coherus BioSciences, Inc. CHRS | STATE STREET CORP STT | 4,619,050 6.410% | 4,619,050 (New Position) | Filing |